El medicamento innovador para vencer la adicción: ¿Ozempic?
Los primeros datos sugieren que los fármacos GLP-1, conocidos por [...]
From AI to Musk’s Brain Chip, the F.D.A.’s Device Unit Faces Rapid Change
The new director overseeing medical devices will confront criticisms about [...]
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain [...]
Why We May Soon Use Ozempic to Treat Addiction
Early data suggests GLP-1 drugs, renowned for their ability to [...]
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest [...]
Hace casi un año se aprobó un fármaco para frenar el alzhéimer. ¿Ha funcionado?
Mientras la FDA estudia otro nuevo medicamento contra el alzhéimer, [...]
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly
The modest benefits of the treatment, donanemab, made by Eli [...]
Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefits
As the F.D.A. considers a new Alzheimer’s medication, we asked [...]
Ozempic Is Repairing a Hole in Our Diets Created by Processed Foods
Now is our chance to rethink the centuries-old stories we’ve [...]
Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’s
People with two copies of the gene variant APOE4 are [...]